# MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

> **NCT02673021** · NA · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 9 (actual)

## Conditions studied

- Lung Neoplasms
- Cancer of Lung
- Cancer of the Lung
- Lung Cancer
- Neoplasms, Lung
- Neoplasms, Pulmonary
- Pulmonary Cancer
- Pulmonary Neoplasms
- Metastatic Cancer to the Lung

## Interventions

- **PROCEDURE:** Microwave ablation

## Key facts

- **NCT ID:** NCT02673021
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06-08
- **Primary completion:** 2020-03-13
- **Final completion:** 2020-03-13
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Funding suspended prior to completing enrollment of all participants.
- **Last updated:** 2023-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02673021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02673021, "MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02673021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*